ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue7/31/20177/31/20167/31/2015
Total Revenue107,804102,77397,599
Cost of Revenue59,47857,19054,772
Gross Profit48,32645,58342,827
Operating Expenses
Research Development2,9283,5243,350
Selling General and Administrative44,01043,58641,069
Non Recurring4,454-48,530-386
Others---
Total Operating Expenses---
Operating Income or Loss-3,06647,003-1,206
Income from Continuing Operations
Total Other Income/Expenses Net260-352-841
Earnings Before Interest and Taxes-2,42246,515-2,292
Interest Expense---
Income Before Tax-2,42246,515-2,292
Income Tax Expense821,229-7
Minority Interest---
Net Income From Continuing Ops-2,50445,286-2,285
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,50445,286-2,285
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,50445,286-2,285